mmaeAgricultural BiotechnologyUpdated on Dec 10, 2018 View more like this | Visit SHIRLEY, NY | Contact Bella Smith |

This ADC product is composed of an anti-HER2 antibody (Trastuzumab) conjuagated via a AO-MC linker to MMAE (Trastuzumab-AO-MC-MMAE). It has demonstrated a response in breast, ovarian and lung cancer treatment by a MOA (Mechanism of Action) of Depolymerize Microtubules.